What's in Kim, Seok Jin's pipeline?

Kim, Seok Jin has 2 drugs in our index: 1 marketed, 0 filed, 0 in Phase 3, 1 in Phase 2, 0 in Phase 1.

Which companies overlap with Kim, Seok Jin's portfolio?

Top competitors by shared drug class: Baim Institute for Clinical Research, Bayer, Bristol-Myers Squibb, China National Center for Cardiovascular Diseases, GlaxoSmithKline.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/kim-seok-jin.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-17 · How we verify

Kim, Seok Jin — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Kim, Seok Jin pipeline: 1 marketed, 0 filed, 0 Phase 3, 1 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

1 marketed 0 filed 0 Phase 3 1 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
RB	RB	marketed	Factor Xa inhibitor	Factor Xa	Cardiovascular

Therapeutic area mix

Cardiovascular · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Baim Institute for Clinical Research · 1 shared drug class
Bayer · 1 shared drug class
Bristol-Myers Squibb · 1 shared drug class
China National Center for Cardiovascular Diseases · 1 shared drug class
GlaxoSmithKline · 1 shared drug class
Hoffmann-La Roche · 1 shared drug class
NYU Langone Health · 1 shared drug class
Paul Di Cesare,MD · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Kim, Seok Jin:

Cite this brief

Drug Landscape (2026). Kim, Seok Jin — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/kim-seok-jin. Accessed 2026-05-17.